WuXi Biologics hatches new baby with ADC drug unit IPO 藥明生物分拆藥明合聯(lián) “藥明系”港股再?zèng)_刺
The drug outsourcing services company is spinning off its WuXi XDC unit, seizing on investor enthusiasm for a new generation of highly targeted ADC drugs 乘著市場(chǎng)對(duì)ADC藥物的熱度,藥明生物通過分拆藥明合聯(lián)在資本市場(chǎng)吸金